• >>
  • Pharmaceuticals and Healthcare

Tetanus Toxoid Vaccine Market: Global Market Synopsis, Growth Factors, Industry Segmentation, Regional Analysis And Competitive Analysis 2017 - 2025

ID: 178242
April, 2018
Region : Global
Pages
CHOOSE LICENCE TYPE

COVID-19


Understand the influence of COVID-19 on the Tetanus Toxoid Vaccine Market with our analysts monitoring the situation across the globe.






Description

Tetanus Toxoid Vaccine Market


Market Synopsis:

Tetanus vaccine is also referred to as tetanus toxoid (TT). It is an inactive vaccine used to prevent tetanus. Tetanus is a severe illness that causes convulsions and serious muscle spasms that can be strong enough to cause bone fractures of the spine. It causes death in 30 to 40 percent of cases. Moreover, tetanus vaccine is available as monovalent tetanus toxoid (TT), in bivalent combination with diphtheria toxoid (DT) or low-dose diphtheria toxoid (Td), or as trivalent vaccine that also includes whole-cell (wP) or acellular (aP) pertussis vaccine.


The major factor for the market growth such as being one of the most effective, least expensive and best tolerated vaccines are heading the market towards the increasing use of such vaccination. Increasing concern and awareness regarding vaccination in developing countries in recent years can also be considered as another driving factor for the market. Vaccination is the main weapon for disease control in developing countries, also the only way of eliminating tetanus in developed countries. However, the restraints of the market are redness and pain at the site of injection, fever, and fatigue, and muscles pains. Serious allergic reactions which occurs in less than one in 100,000 people are most severe side effects of tetanus toxoid vaccine.


For instance, in April 2018, The Uganda National Immunisation Advisory Group (UNITAG) wants the Government to recommend for the tetanus diphtheria other than the current tetanus toxoid.


Market segmentation:

The global tetanus toxoid vaccine market is bifurcated into various segments such as by type, by forms, by end-user, and by region. Based on the type of market, it is segmented into monovalent tetanus toxoid (TT), diphtheria, tetanus, & pertussis (DTaP), diphtheria & tetanus (DT), tetanus, diphtheria, & pertussis (Tdap), and others. According to the forms, the market is segmented as quadrivalent, pentavalent, and hexavalent. On the basis of end-user, the market is classified into biotech & hospitals & clinics, government organizations, research, and others.


Regional analysis:

According to the geographical overview, the market is bifurcated into various regions such as North America, Europe, APAC, and LAMEA. North America is a leading region of this market due to greater use of medications and greater expenditure on healthcare.


Key Players:

On the basis of competitive analysis, the market comprises with major key players including GlaxoSmithKline Plc., Merck & Co. Inc., Pfizer, Inc., Sanofi Pasteur, Inc., AstraZeneca Plc., Bharat Biotech, Shenzhen Kangtai Biological Products, Valeant Pharmaceuticals, Emergent Biosolutions Inc., Astellas Pharma Inc., Panacea Biotec and others.



Tetanus Toxoid Vaccine Market Segmentation


By Type: 

• Monovalent Tetanus Toxoid (TT)

• Diphtheria, Tetanus, & Pertussis (DTaP),

• Diphtheria & Tetanus (DT)

• Tetanus, Diphtheria, & Pertussis (Tdap)

• Others


By Forms:

• Quadrivalent

• Pentavalent

• Hexavalent


By End-User: 

• Biotech & Hospitals & Clinics

• Government Organizations

• Research

• Others


Regions Covered:

• North America 

• Europe

• Asia-Pacific 

• LAMEA

Research Scope


 

The study for Global Tetanus Toxoid Vaccine Market will provide market size, estimates and forecast based on the following years: 

 

Historic data: 2015  Base Year Estimate: 2016  Forecast: 2017 to 2025


The report has been categorized in two distinctive sections, where the first category titled as Market Overview provides a holistic view of the market, key trends, drivers, challenges/restraints or opportunities with their current and expected impact on the overall industry sales. 

Our analyst implement several qualitative tools such as Ansoff’s Matrix, PESTEL analysis, Porter’s five force analysis among other to interpret and represent key industry findings. 

The second section of the study provides market size, estimates and forecast for key market segments and regional market. The final part of the report highlights key manufacturers/vendors operating in the associated market. 


1. Introduction

1.1. Market Definition

1.2. Market Scope


2. Research Methodology

2.1. Primary Research

2.2. Secondary Sources

2.3. Assumptions & Exclusions


3. Market Overview

3.1. Research Report Segmentation & Scope

3.2. Key Market Trend Analysis

3.2.1. Market Drivers

3.2.2. Market Restraint/Challenges

3.2.3. Market Opportunities

3.3. Porter’s Five Forces Analysis

3.4. Potential Venture Avenues

3.5. Market Share Analysis, 2016 


4. Type Overview

4.1. Introduction

4.2. Market Size & Forecast, 2015 to 2025

4.2.1. Monovalent Tetanus Toxoid (TT)

4.2.2. Diphtheria, Tetanus, & Pertussis (DTaP),

4.2.3. Diphtheria & Tetanus (DT)

4.2.4. Tetanus, Diphtheria, & Pertussis (Tdap)

4.2.5. Others

(Note: The segments mentioned above are tentative in nature and are subject to change as the research progresses)


5. Forms Overview

5.1. Introduction

5.2. Market Size & Forecast, 2015 to 2025

5.2.1. Quadrivalent

5.2.2. Pentavalent

5.2.3. Hexavalent

(Note: The segments mentioned above are tentative in nature and are subject to change as the research progresses)


6. End-User Overview

6.1. Introduction

6.2. Market Size & Forecast, 2015 to 2025

6.2.1. Biotech & Hospitals & Clinics

6.2.2. Government Organizations

6.2.3. Research

6.2.4. Others

(Note: The segments mentioned above are tentative in nature and are subject to change as the research progresses)


7. Regional Overview

7.1. Introduction

7.2. Market Size & Forecast, 2015 to 2025

7.2.1. North America

7.2.1.1. U.S.

7.2.1.2. Canada

7.2.1.3. Mexico 

7.2.2. Europe

7.2.2.1. UK

7.2.2.2. Germany

7.2.2.3. France

7.2.2.4. Italy 

7.2.2.5. Spain

7.2.2.6. Rest of Europe

7.2.3. Asia-Pacific

7.2.3.1. China

7.2.3.2. India

7.2.3.3. Japan

7.2.3.4. South Korea

7.2.3.5. Rest of Asia-Pacific

7.2.4. LAMEA

7.2.4.1. Brazil

7.2.4.2. UAE

7.2.4.3. South Africa

7.2.4.4. Rest of LAMEA

(Note: The segments mentioned above are tentative in nature and are subject to change as the research progresses)


8. Manufacturer/ Vendor Profile

8.1. The following attributes will be considered while profiling key manufacturers in this industry: 

8.1.1. Company Overview

8.1.2. Financial Synopsis

8.1.3. Recent Developments

8.1.4. R&D Investments (if any)

8.1.5. Strategy Overview (Analyst Perspective)

8.1.6. Product Portfolio

8.2. Companies Profiled

8.2.1. GlaxoSmithKline Plc.

8.2.2. Merck & Co. Inc.

8.2.3. Pfizer, Inc.

8.2.4. Sanofi Pasteur Inc.

8.2.5. AstraZeneca Plc.

8.2.6. Bharat Biotech

8.2.7. Shenzhen Kangtai Biological Products

8.2.8. Valeant Pharmaceuticals

8.2.9. Emergent Biosolutions Inc.

8.2.10. Astellas Pharma Inc.

8.2.11. Panacea Biotec 

(Note: The companies mentioned above are tentative in nature, and profiles of other market players not listed here can be included on request.)


What's Included

  • Market Size
  • Market Share
  • Market Segmentation
  • Market Forecast
  • Regional Segment Analysis
  • Compound Annual Growth Rate
  • Company & Brand Details
  • Market Revenue and Growth Opportunities
  • Safe and Secure

FAQ's

By product type
By End User/Applications
By Technology
By Leading Industry Players
By Region
We will send you an email with login credentials to access the report. You will also be able to download the pdf.
The study on the impact of COVID-19 on the global market is classified into different segments and analysed based on regions, including North America, Europe, Asia-Pacific, and Rest of World.

Report ID :178242

Published Date :April, 2018

Category :Pharmaceuticals and Healthcare

Pages : Pages

Why Choose Us

  • Lowest Price Guarantee
  • We offer the lowest prices for the listed reports

  • Data Security
  • Your data is safe and secure

  • Vast Report Database
  • We have more than 2 Million reports in our database

  • Client Focused
  • Personalized updates and 24*7 support

  • Trusted Source and Quality
  • We only work with reputable partners providing high quality research and support

  • Market Segmentation
  • We provide alternative views of the market to help you identify where the real opportunities lie

  • Bulk Discounts
  • We offer great discounts on purchase of multiple reports



Every Sample Will Help to Understand

  • Report Structure and Outline
  • Detailed Table of Content (Including List of Tables and Figures)
  • Research Methodology

Report ID :178242

Published Date :April, 2018

Category :Pharmaceuticals and Healthcare

Pages : Pages

Why Choose Us

  • Lowest Price Guarantee
  • We offer the lowest prices for the listed reports

  • Data Security
  • Your data is safe and secure

  • Vast Report Database
  • We have more than 2 Million reports in our database

  • Client Focused
  • Personalized updates and 24*7 support

  • Trusted Source and Quality
  • We only work with reputable partners providing high quality research and support

  • Market Segmentation
  • We provide alternative views of the market to help you identify where the real opportunities lie

  • Bulk Discounts
  • We offer great discounts on purchase of multiple reports



Tetanus Toxoid Vaccine Market: Global Market Synopsis, Growth Factors, Industry Segmentation, Regional Analysis And Competitive Analysis 2017 - 2025

Request COVID-19 Impact Analysis

We understand the economic repercussions of the pandemic and are dedicated towards helping our clients strategize with rapidly changing market scenario,
  • Impact of COVID on supply/demand scenario, trade landscape & supply chain
  • How market participants are preparing/strategizing to combat the impact
  • How does the short-term & long-term scenario for Tetanus Toxoid Vaccine Market looks like

Report ID :178242

Published Date :April, 2018

Category :Pharmaceuticals and Healthcare

Pages : Pages

Why Choose Us

  • Lowest Price Guarantee
  • We offer the lowest prices for the listed reports


  • Data Security
  • Your data is safe and secure


  • Vast Report Database
  • We have more than 2 Million reports in our database


  • Client Focused
  • Personalized updates and 24*7 support


  • Trusted Source and Quality
  • We only work with reputable partners providing high quality research and support


  • Market Segmentation
  • We provide alternative views of the market to help you identify where the real opportunities lie


  • Bulk Discounts
  • We offer great discounts on purchase of multiple reports